Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials.
Saved in:
| Title: | Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials. |
|---|---|
| Authors: | Viviani S; Division of Onco-Hematology, IEO, European Institute of Oncology, IRCCS, Milano, Italy. simonetta.viviani@ieo.it.; Department of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. simonetta.viviani@ieo.it., Pavoni C; Department of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy., Barrington SF; King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK., Guerra L; School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.; Department of Nuclear Medicine, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Schöder H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Johnson P; Cancer Research UK Centre, University of Southampton, Southampton, UK., Kirkwood AA; Cancer Research UK and University College London Cancer Trials Centre, London, UK., Stephens DM; Division of Hematology, University of North Carolina, Chapel Hill, NC, USA., Friedberg JW; Division of Hematology/Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA., Chauvie S; Division of Medical Physics, Santa Croce e Carle Hospital, Cuneo, Italy., Knopp MV; Department of Radiology, Wright Center of Innovation in Biomedical Imaging, The Ohio, State University Wexner Medical Center, Columbus, OH, USA., Luminari S; Hematology Division, Azienda USL IRCCS of Reggio Emilia, Reggio Emilia, Italy., Molin D; Department of Immunology Genetics, and Pathology Cancer Immunotherapy Uppsala, University Uppsala Akademiska Hospital, Uppsala, Sweden., Corradini P; Department of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Gallamini A; Research and Innovation Department, A. Lacassagne Cancer Center, Nice, France., Rambaldi A; Department of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy.; Department of Oncology and Hematology, University of Milano, Milano, Italy., Tarella C; Division of Onco-Hematology, IEO, European Institute of Oncology, IRCCS, Milano, Italy. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Oct 16; Vol. 15 (1), pp. 165. Date of Electronic Publication: 2025 Oct 16. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41102172 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Viviani+S%22">Viviani S</searchLink>; Division of Onco-Hematology, IEO, European Institute of Oncology, IRCCS, Milano, Italy. simonetta.viviani@ieo.it.; Department of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. simonetta.viviani@ieo.it.<br /><searchLink fieldCode="AU" term="%22Pavoni+C%22">Pavoni C</searchLink>; Department of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Barrington+SF%22">Barrington SF</searchLink>; King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK.<br /><searchLink fieldCode="AU" term="%22Guerra+L%22">Guerra L</searchLink>; School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.; Department of Nuclear Medicine, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.<br /><searchLink fieldCode="AU" term="%22Schöder+H%22">Schöder H</searchLink>; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+P%22">Johnson P</searchLink>; Cancer Research UK Centre, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Kirkwood+AA%22">Kirkwood AA</searchLink>; Cancer Research UK and University College London Cancer Trials Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22Stephens+DM%22">Stephens DM</searchLink>; Division of Hematology, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Friedberg+JW%22">Friedberg JW</searchLink>; Division of Hematology/Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Chauvie+S%22">Chauvie S</searchLink>; Division of Medical Physics, Santa Croce e Carle Hospital, Cuneo, Italy.<br /><searchLink fieldCode="AU" term="%22Knopp+MV%22">Knopp MV</searchLink>; Department of Radiology, Wright Center of Innovation in Biomedical Imaging, The Ohio, State University Wexner Medical Center, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Luminari+S%22">Luminari S</searchLink>; Hematology Division, Azienda USL IRCCS of Reggio Emilia, Reggio Emilia, Italy.<br /><searchLink fieldCode="AU" term="%22Molin+D%22">Molin D</searchLink>; Department of Immunology Genetics, and Pathology Cancer Immunotherapy Uppsala, University Uppsala Akademiska Hospital, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Corradini+P%22">Corradini P</searchLink>; Department of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Gallamini+A%22">Gallamini A</searchLink>; Research and Innovation Department, A. Lacassagne Cancer Center, Nice, France.<br /><searchLink fieldCode="AU" term="%22Rambaldi+A%22">Rambaldi A</searchLink>; Department of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy.; Department of Oncology and Hematology, University of Milano, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Tarella+C%22">Tarella C</searchLink>; Division of Onco-Hematology, IEO, European Institute of Oncology, IRCCS, Milano, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2025 Oct 16; Vol. 15 (1), pp. 165. <i>Date of Electronic Publication: </i>2025 Oct 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41102172 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41408-025-01364-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 165 Titles: – TitleFull: Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Viviani S – PersonEntity: Name: NameFull: Pavoni C – PersonEntity: Name: NameFull: Barrington SF – PersonEntity: Name: NameFull: Guerra L – PersonEntity: Name: NameFull: Schöder H – PersonEntity: Name: NameFull: Johnson P – PersonEntity: Name: NameFull: Kirkwood AA – PersonEntity: Name: NameFull: Stephens DM – PersonEntity: Name: NameFull: Friedberg JW – PersonEntity: Name: NameFull: Chauvie S – PersonEntity: Name: NameFull: Knopp MV – PersonEntity: Name: NameFull: Luminari S – PersonEntity: Name: NameFull: Molin D – PersonEntity: Name: NameFull: Corradini P – PersonEntity: Name: NameFull: Gallamini A – PersonEntity: Name: NameFull: Rambaldi A – PersonEntity: Name: NameFull: Tarella C IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 10 Text: 2025 Oct 16 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2044-5385 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Blood cancer journal Type: main |
| ResultId | 1 |